EC Number   |
Inhibitors |
Structure |
|---|
   1.14.14.3 | 2,2-diphenylpropylamine |
- |
   |
| 1.14.14.3 | 2,3-Dichloro-(6-phenylphenoxy)ethylamine |
- |
|
| 1.14.14.3 | 2,4-dinitrofluorobenzene |
i.e. Sanger's reagent |
|
| 1.14.14.3 | 2-Bromodecanal |
protection by dithiothreitol or mercaptoethanol |
|
| 1.14.14.3 | 2-diethylaminoethyl-2,2-diphenylvalerate |
- |
|
| 1.14.14.3 | 2-methyl-1,4-benzoquinone |
- |
|
| 1.14.14.3 | 2-methyl-5-isopropyl-1,4-benzoquinone |
- |
|
| 1.14.14.3 | 5-decyl-4a-hydroxy-4a,5-dihydroriboflavin-5'-phosphate |
binding and fluorescence quantum yield studies of the substance as a model, complexed with the enzyme in a 1:1 molcular ratio leading to 80% and 90% inhibition of wild-type and mutant C106A at 0.01 mM, respectively, binds to the active site |
|
| 1.14.14.3 | 6-(3'-(R)-myristyl) flavin adenine mononucleotide |
binds noncovalently to the enzyme dimer. Addition of recombinant apo-LuxF captures myrFMN and thereby relieves the inhibitory effect |
|
| 1.14.14.3 | 8-Anilino-1-naphthalenesulfonate |
- |
|
